EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Establishment of immortalized rabbit bone marrow mesenchymal stem cells and a preliminary study of their osteogenic differentiation capability

Yao Zhang, Chang Xu, Yun Huang, Dongmei Tan, Wenping Luo, Yan Zhang, Yi Tan

Animal Models and Experimental Medicine · 2024

DOI: 10.1002/ame2.12513 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Animal Models and Experimental Medicine, 2024. Verfasst von Yao Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Animal Center, Chongqing Medical University, Chongqing, China. Hauptthemen laut MEDLINE: Mesenchymal Stem Cells, Osteogenesis, Cell Differentiation, Growth Differentiation Factor 2. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

A stable and standardized source of mesenchymal stem cells is a prerequisite for bone repair tissue engineering research and application. We aimed to establish a stable cell line of bone marrow mesenchymal stem cells from New Zealand rabbits and explore their osteogenic differentiation capacity.

Methods

Primary rabbit bone marrow mesenchymal stem cells (RBMSCs) were isolated and immortalized via retroviral expression of SV40 Large T antigen (LTA). To assess the osteogenic differentiation capacity of the cells in vitro, we studied the alkaline phosphatase (ALP) expression level and calcium deposition in bone morphogenetic protein 9 (BMP9)‐induced immortalized cells using ALP staining and quantification, as well as alizarin red staining. Ectopic bone formation by the cells was assessed using micro‐computed tomography (μCT) and histological examination.

Results

The immortalized cell line we established using SV40 LTA, which we termed iRBMSCs, was non‐tumorigenic and maintained long‐term proliferative activity. We further discovered that BMP9 (MOI = 30) effectively induced the osteogenic differentiation capacity of iRBMSCs in vitro, and there was a synergy with GelMA hydrogel in inducing osteogenic differentiation of the iRBMSCs in vivo.

Conclusion

We confirmed that iRBMSCs are promising as a stable cell line source for bone defect repair engineering.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mesenchymal Stem CellsOsteogenesisCell DifferentiationGrowth Differentiation Factor 2AnimalsRabbitsBone Marrow CellsTissue Engineering

Stichwörter der Autor:innen

GelMA hydrogelbone marrow mesenchymal stem cellsbone morphogenetic protein 9immortalization

Substanzen

Growth Differentiation Factor 2

Autor:innen und Institutionen

  • Laboratory of Animal Center, Chongqing Medical University, Chongqing, China.
  • Laboratory of Animal Center, Southwest University, Chongqing, China.
  • Stomatological Hospital of Chongqing Medical University, Chongqing, China.

Zitieren

APA

Zhang, Y., Xu, C., Huang, Y., Tan, D., Luo, W., Zhang, Y., & Tan, Y. (2024). Establishment of immortalized rabbit bone marrow mesenchymal stem cells and a preliminary study of their osteogenic differentiation capability. Animal Models and Experimental Medicine. https://doi.org/10.1002/ame2.12513

Vancouver

Zhang Y, Xu C, Huang Y, Tan D, Luo W, Zhang Y, et al. Establishment of immortalized rabbit bone marrow mesenchymal stem cells and a preliminary study of their osteogenic differentiation capability. Animal Models and Experimental Medicine. 2024. doi:10.1002/ame2.12513

BibTeX
@article{Zhang2024,
  author = {Zhang, Yao and Xu, Chang and Huang, Yun and Tan, Dongmei and Luo, Wenping and Zhang, Yan and Tan, Yi},
  title = {Establishment of immortalized rabbit bone marrow mesenchymal stem cells and a preliminary study of their osteogenic differentiation capability},
  journal = {Animal Models and Experimental Medicine},
  year = {2024},
  doi = {10.1002/ame2.12513}
}
Kostenlos starten →